Figure 3From: The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study Reasons for switching or discontinuing therapy at the first evaluation (A) and 1 year (B). At the first evaluation examination, patients had been on their current DMT for at least 2 years.Back to article page